Provided by Tiger Fintech (Singapore) Pte. Ltd.

Arcus Biosciences Inc.

8.26
-0.1500-1.78%
Volume:175.29K
Turnover:1.44M
Market Cap:874.21M
PE:-2.63
High:8.34
Open:8.08
Low:8.07
Close:8.41
Loading ...

HC Wainwright Upgrades Arcus Biosciences to Buy From Neutral, Adjusts Price Target to $24 From $18

MT Newswires Live
·
26 Feb

Arcus Biosciences Inc : H.c. Wainwright Raises to Buy From Neutral; Raises Target Price to $24

THOMSON REUTERS
·
26 Feb

Arcus Biosciences (RCUS) Receives a Buy from Barclays

TIPRANKS
·
26 Feb

Arcus Biosciences, Inc. (RCUS) Reports Q4 Loss, Tops Revenue Estimates

Zacks
·
26 Feb

Arcus Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
26 Feb

Arcus Biosciences Q4 EPS $(1.03) Beats $(1.32) Estimate, Sales $36.00M Beat $28.90M Estimate

Benzinga
·
26 Feb

Arcus Biosciences Q4 Operating Expenses USD 139 Million

THOMSON REUTERS
·
26 Feb

Arcus Biosciences Inc: Qtrly Net Loss per Share $1.03

THOMSON REUTERS
·
26 Feb

Arcus Biosciences Reports Fourth-Quarter and Full-Year 2024 Financial Results and Provides a Pipeline Update

Business Wire
·
26 Feb

Arcus Biosciences Announces New Employment Inducement Grants

Business Wire
·
25 Feb

Arcus Biosciences Inc expected to post a loss of $1.25 a share - Earnings Preview

Reuters
·
22 Feb

These Analysts Just Made A Decent Downgrade To Their Arcus Biosciences, Inc. (NYSE:RCUS) EPS Forecasts

Simply Wall St.
·
20 Feb

BRIEF-Arcus Biosciences To Offer 13.6 Million Shares At $11.00 Per Share

Reuters
·
20 Feb

Arcus Biosciences Inc - to Offer 13.6 Mln Shares at $11.00 per Share

THOMSON REUTERS
·
20 Feb

Arcus Biosciences Down Over 14%, on Track for Lowest Close Since March 2020 -- Data Talk

Dow Jones
·
19 Feb

Wedbush Cuts Arcus Biosciences' Price Target to $33 From $36, Keeps Outperform Rating

MT Newswires Live
·
19 Feb

Arcus Biosciences Shares Hit 52-Week Low After $150M Stock Offering

Dow Jones
·
19 Feb

Arcus Biosciences Is Maintained at Overweight by Morgan Stanley

Dow Jones
·
19 Feb

Arcus Biosciences falls -14.8%

TIPRANKS
·
19 Feb

Arcus Biosciences price target lowered to $18 from $20 at H.C. Wainwright

TIPRANKS
·
19 Feb